BTM Nanodesign develops protein-based nanomaterials for biotechnological applications. Our material portfolio includes nanomaterials that have a superior antibody binding capacity, compared with alternative products on the market. In addition, our materials are produced sustainably using only microorganisms.
The company is privately owned and located in Uppsala, Sweden. It was founded in 2019 by researchers at the Swedish University of Agricultural Sciences (SLU).